Introduction
MR imaging is a noninvasive and a useful modality for depicting a wide variety of uterine tumors with excellent tissue contrast. Although transvaginal ultrasonography (TVUS) is widely accepted as the initial modality of choice for evaluating patients with abnormal genital bleeding or infertility, MR imaging can serve as the problem-solving modality when the tissue characterization of the uterine lesion is difficult on TVUS. The characteristics of MR imaging results in several advantages: 1) the evaluation of tumor extent; 2) the demonstration of the internal architecture of the mass, such as cyst formation, hemorrhage, and necrosis; and 3) the determination of tumor origin, i.e., whether it arises from the endometrium, submucosal region, or myometrium.
In case of endometrial carcinomas, MR imaging is usually performed after establishment of the diagnosis. Thereafter, the main role of MR imaging is to evaluate local extension of the tumor, especially with respect to myometrial invasion, cervical invasion, and the presence of extrauterine disease. When the endometrial carcinomas are suspected, the combined use of gadolinium-based contrast media is preferred, because the depth of myometrial invasion can be well evaluated in dynamic enhanced MR image obtained by bolus injection of the contrast material.
In case of myometrial lesions, the diagnosis of the tumors frequently depends on MR findings, because these lesions cannot be approached by hysteroscopic biopsies. In myometrial lesion, MR imaging also is expected to differentiate benign and malignant myometrial tumors. When malignant myometrial tumor is suspected, contrast-enhanced images is useful for differential diagnosis and may provide better contrast of the boundary and the internal architecture of the tumor. In differentiating malignant uterine tumors from benign conditions, in addition to filtration into the surrounding tissues, the presence of necrosis that is usually better demonstrated on postcontrast images is important imaging finding.
One of the recent topics in MR imaging is the application of diffusion-weighted imaging (DWI) in the female pelvic region [1•] . DWI is an emerging technique used to show tissue characteristics based on diffusion motion of water molecules that is known as Brownian motion [2] . The utility of this technique has been initially established in the central nervous system, mainly for the diagnosis of acute stroke [3, 4] . With the recent advent of fast MR imaging techniques, DWI of the abdomen has become possible with short acquisition times [5] . One of the greatest advantages of DW imaging in the abdomen is that this technique delineates lesions of increased cellularity, which are represented by malignant tumors, as in a region of increased signal intensity with excellent tissue contrast [6] [7] [8] . DWI also can provide quantitative measurement of apparent diffusion coefficient (ADC) value, which is considered to be influenced by nuclear-to-cytoplasm ratio and cellular density in solid tissues [9] [10] [11] . In uterine tumors, carcinomas and sarcomas are demonstrated as increased intensity, whereas normal endometrium and benign myometrial tumors have decreased intensity [12] [13] [14] .
The purpose of this article is to revisit the utility of MR imaging by reviewing a spectrum of MR imaging findings in representative corpus tumors. In this review, uterine tumors are roughly divided into benign and malignant, endometrial, and myometrial tumors. Although endometrial stromal sarcomas and undifferentiated stromal sarcomas are considered as endometrial origin, findings in these tumors are described in malignant myometrial tumors, because these tumors may show extensive myometrial invasion or present as myometrial tumor.
Benign Endometrial Tumors

Endometrial Polyps
Endometrial polyps represent the most common uterine endometrial pathologic finding, characterized by localized overgrowth of endometrial glandular and stromal tissue covered by epithelium. Polyps may originate anywhere in a b (Fig. 1 ) [15] . Otherwise, endometrial polyps can be considered to represent mere endometrial thickening. The stalks of endometrial polyps are not usually apparent on MR imaging, as fluid does not outline the polyps. Endometrial polyps are more frequently seen in women taking Tamoxifen for breast carcinoma [16] . Endometrial polyps associated with Tamoxifen are usually large (mean diameter 5 cm) and cystic glandular dilatation and stromal proliferation can be prominent [17] .
Adenomyoma/Adenofibromas
When the stroma is predominantly composed of smooth muscle fibers or fibrous stroma, the lesions are designated as polypoid adenomyomas and adenofibroma, respectively. Polypoid adenomyomas accounts for approximately 2 % of all endometrial polyps and are typically seen in premenopausal women. Atypical polypoid adenomyoma (APA) is a rare variant of a polypoid adenomyoma, microscopically characterized by architectural and cytologic atypia. These tumors most frequently present as pedunculated or sessile polypoid masses in the lower uterine segment or endocervix [18] . On MR imaging, the lesion typically presents as a hypointense polypoid mass [19, 20] . Adenomyoma may contain cystic space of bright intensity, resulting from menstrual hemorrhage, and is called cystic adenomyoma ( a b Fig. 3 Endometrioid carcinoma in a 30-year-old woman. a Sagittal T2-weighted image demonstrates an illdefined area of decreased intensity in the thickened endometrium (arrows). b Postcontrast T1-weighted image demonstrates poorly enhanced tumor in the endometrium (arrows). In both images, the endometrialmyometrial border is well preserved, suggesting the tumor is confined within the endometrium a b Fig. 4 Endometrioid carcinoma in 53-year-old woman. a Sagittal T2-weighted image demonstrates an ill-defined endometrial tumor. The endometrial-myometrial border is almost entirely obscured, suggesting the myometrial invasion by the tumor. b Earlyphase image of dynamic enhanced T1-weighted clearly demonstrates inner myometrium of strong enhancement (arrowheads), which become irregular by invading tumor
Malignant Endometrial Tumors
Endometrial Carcinomas
Endometrial carcinoma is the most common gynecologic malignancy; 95 % of endometrial carcinomas occur in women who are older than age 40 years [22] . MR imaging findings of endometrial carcinomas can vary from a polypoid endometrial mass to an endophytic tumor infiltrating into the myometrium. The tumors are depicted as foci of either low or high signal intensity on T2-weighted images and of decreased enhancement than the surrounding myometrium on contrast-enhanced, T1-weighted images (Fig. 3 ). Because MR imaging is usually performed after establishment of the diagnosis in patients with endometrial carcinoma, the main role of MR imaging is local staging, especially with respect to myometrial invasion, cervical invasion, and extrauterine disease. The myometrial invasion is suspected by recognition of the disruption or irregularity of the inner myometrium that exhibits distinct low intensity on T2-weighted images, and early enhancement on dynamic contrast MR imaging (Fig. 4) . Cervical stromal invasion is suggested when the stroma of low intensity become disrupted or irregular by the tumor (Fig. 5) The majority of endometrial carcinomas are represented by endometrial carcinoma. Other histologic subtypes of endometrial carcinoma include serous carcinomas, clear cell carcinomas, and small cell carcinomas. These tumors are more frequently associated with deep myometrial invasion, nodal metastases, and a worse prognosis compared with high-grade endometrioid carcinomas [29] [30] [31] [32] . On MR imaging, these carcinomas tend to be exophytic and may occur within an endometrial polyp. In small cell carcinoma, MR imaging may show diffuse and extensive myometrial invasion (Fig. 7 ) [33] .
Adenosarcomas
Adenosarcomas are characterized by benign epithelium and mesenchymal components, which are typically composed of endometrial stromal sarcomatous tissue. Adenosarcomas are commonly large polypoid tumors with an average diameter of 5 cm. Approximately 10 % of adenosarcomas may be associated with sarcomatous overgrowth, in which pure sarcomatous components account for 25 % or more of the tumor [34] . Such tumors frequently invade into the myometrium and have a correspondingly worse prognosis. MR imaging features of adenosarcomas can vary from a bulky polypoid mass to multiple polypoid masses of decreased signal intensity on T2-weighted imaging (Fig. 8) [35] . The tumor may contain higha b Fig. 7 Small cell carcinoma in a 40-year-old woman. a Sagittal T2-weighted image demonstrates a polypoid mass of heterogeneous intensity in the endometrial cavity. The myometrium is diffusely thickened by diffusely infiltrating tumor. The cervix also is involved by the tumor (arrowhead). Extensive lymphadenopathy in the para-aortic region represents nodal metastases (arrows). b Sagittal contrast-enhanced T1-weighted images shows multifocal, unenhanced areas of necrosis a b Fig. 8 Adenosarcoma in a 27-year-old woman. a Sagittal T2-weighted image shows adenosarcoma composed of numerous polypoid mass, which protrude into the endometrial cavity. Multiple punctate foci of high intensity within the tumor represent microscopically dilated glands in the tumor. The disruption of the endometrialmyometrial border and heterogeneously increased intensity in the anterior wall represents invasion of the tumor into the myometrium (arrows). b Postcontrast T1-weighted image shows good enhancement in the tumor intensity foci on T2-weighted images, which are considered to represent dilated epithelial glands.
Carcinosarcomas
Carcinosarcomas account for approximately 2 % of all uterine malignancies and typically affect elderly postmenopausal women [36] . Histologically, carcinosarcomas are characterized by the presence of both epithelial and mesenchymal malignancies. Recent clinicopathologic immunohistochemical and molecular studies have provided compelling evidence that carcinosarcomas should be classified as high-grade variants of endometrioid carcinoma. On MR imaging, carcinosarcoma typically shows a bulky polypoid mass that protrudes into the cervical canal. The tumor typically exhibits low intensity on T1-weighted images and heterogeneously high signal intensity on T2-weighted imaging [37, 38] , associated with foci of extensive hemorrhage and necrosis within the tumor, which show high signal intensity on T1-weighted images, low signal intensity on T2-weighted images, and a lack of enhancement on contrast-enhanced images (Fig. 9 ) [39] .
Benign Myometrial Tumors
Adenomyosis Adenomyosis typically present as either diffuse or focal thickening of the inner myometrium or an ill-defined myometrial mass of low intensity on T2-weighted images (Fig. 2) . The ectopic endometrial tissue within adenomyosis may be depicted as foci of increased intensity (Fig. 10) . These foci may contain hemorrhage of high intensity on T1-weighted images. Occasionally, these ectopic endometrial glands may contain hemorrhage resulting from menstrual bleeding, depicted as foci of a b c high intensity on T1-weighted images [21•, 40] . When these cystic foci become prominent, the lesion is called as adenomyotic cyst. Adenomyotic cyst can be submucosal, intramyometrial, or subserosal.
Leiomyomas
Leiomyomas are the most common uterine tumor, histologically characterized by the benign proliferation of smooth muscles cell separated by variable amounts of collagenous stroma. MR imaging is the most accurate modality for detecting and diagnosing leiomyomas. Leiomyoma typically presents as a well-defined myometrial mass of distinct low intensity on T2-weighted images, reflecting abundant collagenous stroma (Fig. 11 ) [41] . Leiomyomas may show variable MR appearance due to degenerations and unusual growth patterns. Clinically, large subserosal leiomyomas are frequently mistaken as adnexal mass. In those instances, MR imaging is useful in diagnosing the origin of the mass by clearly demonstrating the tumor vessels extending from the myometrium to the tumor, known as bridgingvascular sign (Fig. 12) . Leiomyoma with edema may show heterogeneously increased intensity on T2-weighted images. The typical speckled appearance on T2-weighted images may help to diagnose this type of degenerated leiomyoma [42] . These leiomyomas usually do not contain foci of hemorrhage or necrosis. Cellular leiomyoma is one of the histologic variants characterized by increased cellularity and also shows increased intensity on T2-weighted images. Homogeneous appearance of the tumor favors benign nature of the lesion.
Leiomyoma with red degeneration may contain extensive hemorrhage, which exhibit increased intensity on T1-weighted images, sometimes associated with thick rim of low signal intensity on T2-weighted images (Fig. 13) . Leiomyoma with red degeneration is well circumscribed and do not invade into the adjacent tissues. This peculiar degeneration is considered to be result from hemorrhagic infarction caused by obstruction of drainage veins and typically occurs in young females during pregnancy or from taking oral contraceptives [43] .
Benign uterine leiomyomas may show unusual growth pattern that should not be mistaken for malignancy [42, 44] . Leiomyomas may show extensive venous extension, which is known as intravenous leiomyomatosis. Subserosal uterine leiomyoma extending into the broad ligament or the retroperitoneum also may produce infiltrative appearance. Rarely, submucosal myomas can be pedunculated and prolapse into the cervical canal or vagina [45] .
Malignant Myometrial Tumors
Leiomyosarcoma Leiomyosarcoma represents the most common uterine sarcoma, characterized by tumor cells demonstrating smooth muscle differentiation, associated with prominent coagulative necrosis and marked nuclear atypia. Although the tumors commonly occur in postmenopausal women with a median age of 50-55 years, 15 % of patients are younger than age 40 years [46] . The prognosis is generally poor, with 5-year survival rates of 15-25 % [47] . On MR imaging, leiomyosarcoma presents as an ill-defined tumor mainly located within the myometrium and exhibiting low signal intensity on T1-weighted images and intermediate to high signal intensity on T2-weighted images (Fig. 14) . The foci of intratumoral hemorrhage or necrosis exhibit focal high intensity on T1-weighted images and decreased intensity on T2-weighted images. DWI also is a useful technique that demonstrates sarcomas as increased intensity [14] .
Endometrial Stromal Sarcoma
Endometrial stromal sarcoma (ESS) is the second most common uterine sarcoma and is characterized by proliferation of well-differentiated cells closely resembling cells of endometrial stroma in the proliferative phase of the menstrual cycle. ESS tends to occur in a young age group (mean age 39 years) [48] . Curettage may not be helpful to establish diagnosis, because the cells shed from ESS usually are not sufficiently atypical to be distinguished from benign stromal cells. Nonetheless, despite scant cytologic atypia, ESS tends a b Fig. 13 Red degeneration in a 36-year-old woman. a Sagittal T2-weighted image demonstrates a well-defined myometrial mass of low intensity, associated with thick rim of distinct low signal intensity (arrows). b T1-weighted image reveals entirely increased intensity in the tumor, suggesting red degeneration a b When the tumor is advanced, the 5-year survival rate is unfavorable (40-50 %) [49] . Although MR features of ESS are variable, ranging from a polypoid mass confined within the endometrial cavity to a tumor with an extensive myometrial invasion, commonly the tumor is entirely within the myometrium. The tumors typically exhibit increased signal intensity on T2-weighted imaging. One of the characteristic MR findings is the presence of bands of low signal intensity within the myometrial lesion, which represent preserved myometrial bundles amidst the infiltrating nests of tumors cells (Fig. 15) [48, 49] . As well as leiomyosarcomas, the nest of ESS is depicted as areas of increased intensity on DWI [14] . Hemorrhage and necrosis are unusual in this tumor. Occasionally, the tumor may extend into the broad ligament or adnexa, as well as demonstrate extensive intravenous involvement [48] .
Undifferentiated Endometrial Sarcoma
Undifferentiated endometrial sarcoma is a highly aggressive tumor, characterized by highly anaplastic cells that lack specific differentiation [47, 50] , typically affecting postmenopausal women with a mean age of 61 years at diagnosis. Conventionally, these tumors have been classified as high-grade ESS. Recently, some of these tumors have been considered to be variants of carcinosarcoma without carcinomatous component. Occasionally, undifferentiated endometrial sarcoma may present as an infiltrative mass entirely within the myometrium. Most patients die of tumor dissemination within 3 years. MR features a b of undifferentiated endometrial sarcoma are similar to those in leiomyosarcomas or carcinomasarcomas, characterized by heterogeneous appearance with foci of increased intensity on T1-weighted and low signal intensity on T2-weighted images, reflecting hemorrhage and necrosis within the tumor (Fig. 16 ).
Conclusions
MR imaging is a useful modality for depicting a wide variety of uterine tumors with excellent tissue contrast. When malignant uterine neoplasms are suspected, gadolinium-based contrast material is useful in delineating the tumor extent and internal architecture of the tumor. In addition to conventional technique, DWI also is useful to demonstrate lesion of increased cellularity, represented by malignant tumors. Benign endometrial tumors, such as endometrial polyps, adenofibromas, and adenomyomas, are characterized as polypoid lesions, occasionally associated with multiple intratumoral cysts of high intensity on T2-weighted images. MR imaging findings of endometrial carcinomas can vary from a polypoid endometrial mass to an endophytic tumor infiltrating into the myometrium, of either low or high intensity on T2-weighted images, decreased enhancement than the surrounding myometrium on contrast enhanced T1-weighted images. Both adenosarcomas and carcinosarcomas are typically large polypoid masses, and the latter typically contains extensive hemorrhage and necrosis. Leiomyomas are well-defined masses of low intensity. Endometrial stromal sarcomas are typically infiltrating myometrial mass, preserving the myometrial bundles of low signal intensity within the tumor. Leiomyosarcomas and undifferentiated stromal sarcoma are heterogeneous mass containing hemorrhage and necrosis. The recognition of typical MR imaging features in a wide variety of endometrial tumors may facilitate differentiation, thus better determining appropriate patient management.
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